In a study evaluating the role of HEF1 in CRC tumorigenesis, HEF1 was identified as a novel Wnt signaling target and classified as a biomarker for tumor aggressiveness; overexpression of HEF1 in CRC cells enhanced cell migration and invasion. The gene discussed is NEDD9; the disease is neoplasm.